|
"hsu cc"的相關文件
顯示項目 96-105 / 686 (共69頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-09-24 |
Downregulation of CRTAC1 in urothelial carcinoma promotes tumor aggressiveness and confers poor prognosis
|
Li, WM;Chan, TC;Wei, YC;Li, CF;Ke, HL;Wu, WJ;Hsu, CC;Wang, SC;Yeh, CF |
| 國家衛生研究院 |
2023-09-21 |
Reply to the Letter to the Editor: "Glucagon-like Peptide-1 Receptor Agonists: Best Choice for Patients with Cirrhosis and Diabetes?"
|
Yen, FS;Yu, TS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-09-16 |
Predicting long-term care service demands for cancer patients: A machine learning approach
|
Chien, SC;Chang, YH;Yen, CM;Chen, YE;Liu, CC;Hsiao, YP;Yang, PY;Lin, HM;Lu, XH;Wu, IC;Hsu, CC;Chiou, HY;Chung, RH |
| 國家衛生研究院 |
2023-08-24 |
Roux-en-Y and one-anastomosis gastric bypass surgery are superior to sleeve gastrectomy in lowering glucose and cholesterol levels independent of weight loss: A propensity-score weighting analysis
|
Chang, YC;Hsu, CN;Chong, K;Yang, PJ;Ser, KH;Lee, PC;Chen, SC;Hsuan, CF;Lee, YC;Hsu, CC;Lee, HL;Liao, KC;Hsieh, ML;Chuang, GT;Yang, WS;Chu, SL;Li, WY;Chuang, LM;Lee, WJ |
| 國家衛生研究院 |
2023-08-11 |
Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis
|
Wang, CY;Wu, CH;Chen, HM;Lin, JW;Hsu, CC;Chang, YF;Tai, TW;Fu, SH;Hwang, JS |
| 國家衛生研究院 |
2023-08-08 |
Transitions of dialysis status and outcomes after the unplanned first dialysis: A nationwide population-based cohort study
|
Liao, CT;Lai, JH;Chen, YW;Hsu, YH;Wu, MY;Zheng, CM;Hsu, CC;Wu, MS;Chuang, SY |
| 國家衛生研究院 |
2023-08-07 |
Taiwan renal data report system: Framework, function, and development
|
Lin, MY;Liao, CT;Lin, MH;Wu, HT;Wu, MS;Hsu, YH;Hsu, CC |
| 國家衛生研究院 |
2023-08-03 |
Home-based exercise and nutrition interventions for frailty
|
Hsu, CC |
| 國家衛生研究院 |
2023-06-29 |
Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers
|
Tsai, KK;Bae, BI;Hsu, CC;Cheng, LH;Shaked, Y |
| 國家衛生研究院 |
2023-06-16 |
Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes
|
Yen, FS;Hou, MC;Cheng-Chung Wei, J;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
顯示項目 96-105 / 686 (共69頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
